Color Vision Tied to Bladder Survival

Patients with impaired color perception may be less likely to recognize blood in urine, potentially delaying diagnosis of cancers that rely on visible bleeding as an early warning sign.

By
Kerri Miller
March 10, 2026
5 min

Conexiant

Objective:

To investigate the association between color vision deficiency (CVD) and survival outcomes in patients with bladder cancer and colorectal cancer, highlighting the potential clinical implications of the findings.

Approach:

Key Findings:

Patients with bladder cancer and CVD had lower overall survival compared to matched patients without CVD.
CVD was associated with a 52% higher 20-year mortality risk in bladder cancer patients.
No significant survival difference was found among colorectal cancer patients based on CVD status, indicating a need for further investigation.

Interpretation:

The findings suggest that impaired color perception may delay recognition of visible blood in urine, a key symptom of bladder cancer, while colorectal cancer presents with a broader range of symptoms that may prompt earlier evaluation, highlighting the importance of awareness in clinical settings.

Limitations:

Potential misclassification due to reliance on diagnostic coding.
Undiagnosed CVD may dilute observed effects by including affected patients in comparison cohorts.
Lack of cancer staging data prevents confirmation of disease advancement related to CVD.
Retrospective design limits causal conclusions, necessitating caution in interpretation.

Conclusion:

The study's findings are hypothesis-generating and suggest increased clinical suspicion for bladder cancer in patients with CVD. Future research should explore targeted screening strategies for high-risk patients to improve outcomes.